Investors Slaughter Q32 Bio On A 'Messy' Update In Eczema, Alopecia Treatment
In This Article:
Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record low.
Oops, something went wrong
Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record low.